U.S. FDA approves Parkinson's treatment from Sunovion Pharma

The U.S. Food and Drug Administration on Thursday approved a sublingual film from Sunovion Pharmaceuticals Inc, a unit of Japan-based Sumitomo Dainippon, for the treatment of "off" episodes in patients with Parkinson's disease, according to a label published by the agency.